Champions Oncology Inc. (CSBR)
NASDAQ: CSBR
· Real-Time Price · USD
7.54
-0.12 (-1.57%)
At close: Jun 17, 2025, 10:20 AM
-1.57% (1D)
| Bid | 7.48 |
| Market Cap | 104.25M |
| Revenue (ttm) | 58.59M |
| Net Income (ttm) | 6.43M |
| EPS (ttm) | 0.45 |
| PE Ratio (ttm) | 16.76 |
| Forward PE | 35.2 |
| Analyst | Strong Buy |
| Ask | 7.72 |
| Volume | 14 |
| Avg. Volume (20D) | 38,166 |
| Open | 7.68 |
| Previous Close | 7.66 |
| Day's Range | 7.51 - 7.95 |
| 52-Week Range | 3.60 - 11.99 |
| Beta | 0.37 |
About CSBR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CSBR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CSBR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
+12.09%
Champions Oncology shares are trading higher after...
Unlock content with
Pro Subscription
9 months ago
+9.58%
Champions Oncology shares are trading higher after the company reported better-than-expected Q1 financial results. Also, Craig-Hallum upgraded the stock from Hold to Buy and maintained its $6 price target.
